Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Posts Tagged ‘compared’

« Older Entries

Small cancer risk following CT scans in childhood and adolescence confirmed

By on Wednesday, May 22nd, 2013 | No Comments

Young people who undergo CT scans are 24 percent more likely to develop cancer compared with those who do not, a study published today on bmj.com suggests. However the absolute excess for all cancers combined was low, at 9.38 for every 100,000 person years of follow-up.

Read More...

Study shows advantage to nanotech delivery of therapy for breast cancer brain metastases

By on Tuesday, May 7th, 2013 | No Comments

Breast cancer brain metastases present a challenge to clinicians because there are few systemic therapies capable of crossing the blood-brain barrier to control the disease. An international team, led by scientists at the University of North Carolina Lineberger Comprehensive Cancer Center, reports pre-clinical research showing improved efficacy of a PEGylated liposomal (encapsulated) anti-cancer agent compared with a non-liposomal formulation of the same drug in an intracranial model of breast cancer.

Read More...

TCGA researchers identify potential drug targets, markers for leukemia risk; New study reveals relatively few mutations in AML genomes

By on Thursday, May 2nd, 2013 | No Comments

Investigators for The Cancer Genome Atlas (TCGA) Research Network have detailed and broadly classified the genomic alterations that frequently underlie the development of acute myeloid leukemia (AML), a deadly cancer of the blood and bone marrow. Their work paints a picture of a cancer marked by relatively few mutations compared to other types of cancer occurring in adults.

Read More...

Women with Breast Cancer Micrometastases in Their Sentinel Lymph Nodes May Not Need Axillary Dissection

By on Wednesday, May 1st, 2013 | No Comments

Results from a randomized clinical trial showed that women with breast cancer and only micrometastases in their sentinel lymph nodes who received axillary lymph node dissection had more side effects but no improvement in disease-free survival compared with women who had no further lymph node surgery.

Read More...

How does pregnancy reduce breast cancer risk?

By on Monday, April 29th, 2013 | No Comments

Being pregnant while young is known to protect a women against breast cancer. But why? New research finds that Wnt/Notch signalling ratio is decreased in the breast tissue of mice which have given birth, compared to virgin mice of the same age.

Read More...

Coffee may help prevent breast cancer returning, study finds

By on Friday, April 26th, 2013 | No Comments

Patients who took the pill, along with two or more cups of coffee daily, reported less than half the rate of cancer recurrence, compared with their Tamoxifen-taking counterparts who drank one cup or less.

Read More...

Risk Of Cancer Is 15% Higher In 9/11 Responders

By on Wednesday, April 24th, 2013 | No Comments

The risk of cancer is 15% higher in 9/11 responders compared to the general population not exposed to Ground Zero, according to a new study. The research was conducted by Mount Sinai Hospital’s World Trade Center Health Program and was published in Environmental Health Perspectives. Almost 21,000 rescue and recovery workers who worked at Ground Zero were analyzed in the report…

Read More...

Risk Of Cancer Is 15% Higher In 9/11 Responders

By on Wednesday, April 24th, 2013 | No Comments

The risk of cancer is 15% higher in 9/11 responders compared to the general population not exposed to Ground Zero, according to a new study. The research was conducted by Mount Sinai Hospital’s World Trade Center Health Program and was published in Environmental Health Perspectives. Almost 21,000 rescue and recovery workers who worked at Ground Zero were analyzed in the report…

Read More...

Molecule treats leukemia by preventing cancer cell repair

By on Wednesday, April 17th, 2013 | No Comments

Researchers have identified a molecule that prevents repair of some cancer cells, providing a potential new “genetic chemotherapy” approach to cancer treatment that could significantly reduce side effects and the development of treatment resistance compared with traditional chemotherapy.

Read More...

Two-drug combo more effective in treating sarcomas

By on Wednesday, April 10th, 2013 | No Comments

Researchers have found that when given together, a two-drug combination acts synergistically in test animals modeled with sarcoma tumors. They report that the drug combination of MK-1775 and gemcitabine resulted in a 70 percent decrease in the tumor volume when compared to receiving one drug or the other.

Read More...
« Older Entries